Asia-Pacific Predicted to Witness Surge in Vials Market in Coming Years

1. Rising Healthcare Expenditure Driving Vials Demand 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

2. The outbreak of the COVID-19 infection has augmented the need for medical products in recent years. As the virus is spreading at an exponential rate, people need to vaccinate at a rapid pace in order to protect themselves from the infection. To meet the high demand for vaccines, pharmaceutical companies are heavily investing in the expansion of their production capacities. Moreover, the mushrooming focus of pharmaceutical and biotechnology companies and research organizations on discovering novel drugs to cure the COVID-19 disease will also amplify the need for vials in the foreseeable future. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/vials-market- report/report-sample In addition, the surging healthcare expenditure, primarily on account of soaring awareness regarding health-related issues, is expected to drive the vials market at a CAGR of 8.6% during the forecast period (2021–2030). The market revenue stood at $1,263.0 million in 2020 and it is projected to reach $3,047.0 million by 2030. The escalating expenditure on healthcare in emerging economies, such as China and India, will significantly contribute to the market growth in the coming years. Currently, the market is observing a key trend of growing preference for glass material for vials for the vaccine fill-finish products. Nowadays, vial manufacturers, such as Phoenix Glass LLC, Acme Vial and Glass Company LLC, SGD Pharma, Corning Incorporated, Pacific Vial Manufacturing Inc., O.Berk, Stevanato Group, Gerresheimer AG, SCHOTT AG, Hanna Instruments, and PIRAMIDA d.o.o, are preferring borosilicate glass over fused silica to produce vials, due to the impermeability, thermal stability, and chemical inertness properties of the former glass type. With the launch of COVID vaccination programs, these companies are manufacturing borosilicate vials in large quantities. The end user segment of the vials market is classified into medical, biomedical research organizations, pharmaceutical and biotech companies, and others. Under this segment, the pharmaceutical and biotech companies category is expected to account for the largest market share and exhibit the fastest growth during the forecast period. This can be credited to the soaring demand for high- quality drugs, such as biologics, the rising aging population, the increasing prevalence of age-related ailments, and the booming healthcare spending across the world. According to P&S Intelligence, the European region adopted the highest quantity of vials in the recent past, due to the surging geriatric population and increasing awareness about newly developed drugs in the region. According to the European Union (EU), in 2020, more than 20.6% of the total population of the 27 member nations of the EU was aged 65 years and above. Moreover, the 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

3. presence of leading vial manufacturers, such as Stevanato Group, Schott AG, SGD S.A., and Gerresheimer AG, and the high per capita income of people has also led to the high-volume consumption of vials in Europe. Market Size Breakdown by Segment The global vials market report offers comprehensive market segmentation analysis along with market estimation for the period 2014–2030. Based on Glass Type Borosilicate Fused-Silica Based on End User Pharmaceutical and Biotech Companies • • • oVolumetric filling oLiquid-level filling Biomedical Research Organizations Medical Geographical Analysis North America • • • oU.S. oCanada Europe • oGermany oFrance oU.K. oItaly oSpain oNetherlands APAC • oChina oJapan oIndia oAustralia LATAM Vials Market • oBrazil oMexico oArgentina 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

4. MEA • oSaudi Arabia o South Africa oU.A.E. 4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

5. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved